TABLE OF CONTENTS

4 OVERVIEW

4 Drug Overview

5 Product Profiles

5 Incruse Ellipta : Chronic obstructive pulmonary disease (COPD)

LIST OF FIGURES
8 Figure 1: Incruse for COPD - SWOT analysis

9 Figure 2: Datamonitor Healthcare's drug assessment summary of Incruse for COPD

10 Figure 3: Datamonitor Healthcare's drug assessment summary of Incruse for COPD

13 Figure 4: Incruse sales for COPD across the US, Japan, and five major EU markets, by country, 2017-26

LIST OF TABLES
5 Table 1: Incruse drug profile

7 Table 2: Incruse Phase III data in COPD
14 Table 3: Incruse sales for COPD across the US, Japan, and five major EU markets, by country ($m), 2017-26